Endoscopes and methods of treatment

Information

  • Patent Grant
  • 11931010
  • Patent Number
    11,931,010
  • Date Filed
    Friday, March 24, 2017
    7 years ago
  • Date Issued
    Tuesday, March 19, 2024
    a month ago
Abstract
An endoscope includes a handle, an elongated body extending distally from the handle and defining a longitudinal axis, a light source disposed within the distal portion of the elongated body and configured to illuminate tissue, and a therapeutic unit disposed within the distal portion of the elongated body and configured to treat tissue.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a U.S. National Stage Application filed under 35 U.S.C. § 371(a) which claims the benefit of and priority to International Patent Application Serial No. PCT/CN2017/078142, filed Mar. 24, 2017, the entire disclosure of which is incorporated by reference herein.


TECHNICAL FIELD

The present disclosure relates to endosurgical devices, systems and methods for observing internal features of a body during minimally invasive surgical procedures, and more particularly, to endoscopes including a therapeutic unit and methods of using endoscopes to treat tissue.


BACKGROUND

Endoscopes are introduced through an incision or a natural body orifice to observe internal features of a body. Conventional endoscopes are typically used for visualization during endoscopic or laparoscopic surgical procedures. During such surgical procedures, it is common for tissue to be bluntly or sharply dissected, ligated, and/or sealed. Infections or the like may occur after such surgical procedures due in part to the disruption of tissue.


To help minimize the effects of such infections or the like, postoperative procedures are typically performed. However, postoperative procedures use additional instruments, take additional time, and are thus costly. Accordingly, it may be beneficial to provide an endoscope that can both provide visualization of tissue and provide therapeutic functions to tissue.


SUMMARY

The present disclosure relates to an endoscope including a handle, an elongated body extending distally from the handle and defining a longitudinal axis, a light source disposed within the distal portion of the elongated body and configured to illuminate tissue, and a therapeutic unit disposed within the distal portion of the elongated body and configured to treat tissue.


In disclosed embodiments, the therapeutic unit includes a plurality of LED elements. It is further disclosed that the endoscope includes a controller disposed in electrical communication with the light source and with the therapeutic unit. It is also disclosed that the endoscope includes an image sensor disposed within the distal portion of the elongated body and configured to capture a plurality of images.


According to aspects of the present disclosure, the therapeutic unit produces light energy. It is disclosed that the therapeutic unit is configured to focus the light energy on an area of tissue that is smaller than an area of tissue illuminated by the light source. It is further disclosed that the therapeutic unit includes a light emitting element and a lens. In embodiments, the lens includes a proximal surface and a distal surface. The proximal surface is disposed at first angle with respect to a first axis, and the distal surface disposed at a second angle with respect to the second axis. The first angle is between about 5° and about 15°, the second angle is between about 5° and about 15°, and the first axis is perpendicular to the longitudinal axis.


In disclosed embodiments, the therapeutic unit is configured to emit light having a wavelength raging from about 500 nm to about 650 nm. In embodiments, the therapeutic unit includes one red light, one blue light and one green light.


The present disclosure also relates to a method of treating tissue including positioning an endoscope adjacent tissue, illuminating the tissue using a light source of the endoscope, and treating the tissue using a therapeutic unit of the endoscope.


In disclosed embodiments of the method, illuminating the tissue using the light source includes illuminating a first area of tissue. Additionally, treating the tissue using the therapeutic unit includes focusing light energy on a second area of tissue. The second area of tissue is smaller than the first area of tissue.


In further disclosed embodiments of the method, treating the tissue using the therapeutic unit includes emitting light having a wavelength raging from about 500 nm to about 600 nm from the therapeutic unit to, for example, coagulate blood within the tissue, emitting light having a wavelength of about 570 nm from the therapeutic unit to induce fresh blood cells in the tissue to, for example, produce fluorescence, or emitting light having a wavelength of about 650 nm from the therapeutic unit to, for example, kill gangrene cells within the tissue.


Further details and aspects of various embodiments of the present disclosure are described in more detail below with reference to the appended figures.





BRIEF DESCRIPTION OF THE DRAWINGS

Embodiments of the present disclosure are described herein with reference to the accompanying drawings, wherein:



FIG. 1 is a front, perspective view of an endoscope system of the prior art;



FIG. 2 is front, perspective view illustrating a schematic configuration of the endoscope system of FIG. 1;



FIG. 3 is a side view illustrating a schematic configuration of an optical system of the endoscope system of FIG. 1;



FIG. 4 is a front, perspective view illustrating a schematic configuration of another endoscope system of the prior art;



FIG. 5 is a perspective, partial cutaway view illustrating a schematic configuration of a distal end of an endoscope of the endoscope system of FIG. 4;



FIG. 6 is a perspective view of an endoscope in accordance with embodiments of the present disclosure;



FIG. 7 is a schematic configuration of an endoscope system in accordance with an embodiment of the present disclosure;



FIG. 8 is a longitudinal cross-sectional view of an endoscope in accordance with an embodiment of the present disclosure;



FIG. 9 is an enlarged view of a distal portion of the endoscope of FIG. 8;



FIG. 10 is a schematic transverse, cross-sectional view of the distal portion of the endoscope of FIGS. 8 and 9;



FIG. 11 is a schematic cross-sectional view of the distal portion of the endoscope of FIGS. 8-10 taken along line 11-11 of FIG. 10;



FIG. 12 is a schematic transverse, cross-sectional view of a therapeutic unit of the endoscope of FIGS. 8-11;



FIG. 12A is a schematic diagram illustrating an overlay of two spherical lenses for use with the therapeutic unit of the endoscope of FIGS. 8-12;



FIG. 12B is an enlarged view of the area of detail indicated in FIG. 12;



FIG. 13 is a schematic transverse, cross-sectional view of the distal portion of an endoscope in accordance with an embodiment of the present disclosure; and



FIGS. 14 and 15 are graphs illustrating the relationship between absorption and wavelength of light.





DETAILED DESCRIPTION OF EMBODIMENTS

Embodiments of the presently disclosed endoscopes and methods of treatment are described in detail with reference to the drawings, in which like reference numerals designate identical or corresponding elements in each of the several views. As used herein, the term “distal” refers to that portion of a structure that is farther from a user, while the term “proximal” refers to that portion of a structure that is closer to the user. The term “clinician” refers to a doctor, nurse, or other care provider and may include support personnel. The term “about” shall be understood as a word of approximation that takes into account relatively little to no variation in a modified term (e.g., differing by less than 2%).


Referring initially to FIGS. 1-3, a prior art endoscope system 1 includes an endoscope 10, a light source 20, a video system 30, and a display device 40. The light source 20, such as an LED/Xenon light source, is connected to the endoscope 10 via a fiber guide 22 that is operatively coupled to the light source 20 and to an endocoupler 16 disposed on, or adjacent to, a handle 18 of the endoscope 10. The fiber guide 22 includes, for example, fiber optic cable which extends through the elongated body 12 of the endoscope 10 and terminates at a distal end 14 of the endoscope 10. Accordingly, light is transmitted from the light source 20, through the fiber guide 22, and emitted out the distal end 14 of the endoscope 10 toward a targeted internal feature, such as tissue or an organ, of a body of a patient. As the light transmission pathway in such a configuration is relatively long, for example, the fiber guide 22 may be about 1.0 m to about 1.5 m in length, only about 15% (or less) of the light flux emitted from the light source 20 is outputted from the distal end 14 of the endoscope 10.


The video system 30 is operatively connected to an image sensor 32 mounted to, or disposed within, the handle 18 of the endoscope 10 via a data cable 34. An objective lens 36 is disposed at the distal end 14 of the elongated body 12 of the endoscope 10 and a series of spaced-apart, relay lenses 38, such as rod lenses, are positioned along the length of the elongated body 12 between the objective lens 36 and the image sensor 32. Images captured by the objective lens 36 are forwarded through the elongated body 12 of the endoscope 10 via the relay lenses 38 to the image sensor 32, which are then communicated to the video system 30 for processing and output to the display device 40 via cable 39.


The image sensor 32 is located within, or mounted to, the handle 18 of the endoscope 10, which can be up to about 30 cm away from the distal end 14 of the endoscope 10. Due to this relatively long distance, there is loss of image information in the image retrieval pathway as it is difficult to get a high quality image at every point along the whole working distance of the relay lenses 38. Moreover, due to light loss on the relay lenses 38, the objective lens 36 cannot include a small aperture. Therefore, the depth of field is limited and a focusing module (not shown) is typically utilized in the endocoupler 16 to set the objective lens 36 to a desired focal point, which a clinician adjusts when moving the endoscope 10 during a surgical procedure. Also, rotation of the fiber guide 22 will also rotate the relay lenses 38, which changes the viewing angle during use, and the fiber guide 22 also tends to fall due to the force of gravity. Accordingly, a clinician needs to adjust and/or hold the fiber guide 22 during use to keep the view stable, which is inconvenient during operation.


As shown in FIGS. 4 and 5, another prior art endoscope system 1′, which is substantially similar to endoscope system 1 and therefore will only be described with respect to the differences therebetween, includes the image sensor 32 in a distal portion 13 of the elongated body 12 of the endoscope 10′ such that the image retrieval pathway between the objective lens 36 and the image sensor 32 is shorter than that of the endoscope system 1. The endoscope system 1′ adopts the same light transmission pathway as that of the endoscope system 1 (e.g., from the light source 20 and through the fiber guide 22), and thus light consumption on transmission is still large. However, the fiber guide 22 may be integrated with the data cable 34, thereby making the endoscope 10′ easier to operate as a clinician does not need to adjust the fiber guide 22 during use.


Referring now to FIGS. 6 and 7, an endoscope system 100 of the present disclosure includes an endoscope 110, a display 120, and a cable 130 connecting the endoscope 110 and the display 120. A camera 140, a light source 150, and an integrated processor 160 are contained within the endoscope 110.


The endoscope 110 includes a handle 112 and an elongated body 114 having a cylindrical wall 114a extending distally from the handle 112 and defines a longitudinal axis “x.” The elongated body 114 includes a distal portion 116 terminating at a distal end or tip 118. The handle 112 includes a handle housing 112a including a grip portion 113 for handling by a clinician and a control portion 115 including actuating elements 115a (e.g., buttons, switches etc.) for functional control of the endoscope 110.


With reference to FIGS. 6 and 7, the camera 140 is disposed within the elongated body 114 of the endoscope 110. The camera 140 includes an image sensor 142 disposed within the distal portion 116 of the elongated body 114 at a location proximal of a lens 144 that is positioned at the distal end 118 of elongated body 114. The image sensor 142 may be a charge-coupled device (CCD), a complementary metal-oxide-semiconductor (CMOS), or a hybrid thereof. In embodiments, the image sensor 142 is a highly sensitive, backside illuminated sensor (BSI). In embodiments, the lighting flux required by the image sensor 142 may be up to about 20 lm.


As the image retrieval pathway is shortened over that of traditional endoscope systems (e.g., FIG. 1) and the need for relay lenses is eliminated, the depth of field can be expanded and optimized. Accordingly, the lens 144 may include a depth of field from about 20 mm to about 110 mm with optimized image quality and a field-of-view of about 100 degrees. In embodiments, the lens 144 is a focus free lens. As compared to traditional endoscopes, a focus free lens relies on depth of field to produce sharp images and thus, eliminates the need to determine the correct focusing distance and setting the lens to that focal point. Accordingly, the aperture of the lens 144 can be relatively small, taking up less space at the distal end 118 of the elongated body 114. In embodiments, the outer diameter of the lens 144 is up to about 6 mm.


The light source 150 is disposed at the distal end 118 of the endoscope 110. Light source 150 includes one or more high efficiency light emitting elements 152, such as light-emitting diodes (LED) arranged in an annular ring around the lens 144 to ensure adequate and even light distribution. In embodiments, the light emitting elements 152 have a luminous efficacy of up to about 80 lm/W (lumen/watt). As compared to traditional endoscopes, the light source of the present disclosure reduces or eliminates the need for the use of an external light source and fiber guide, which can lower the cost of the endoscope system, simplify the endoscope system structure, and reduce light consumption and/or light distortion during light transmission. Although light emitting elements 152 may be efficient and produce less heat than other types of lighting, light emitting elements 152 still produce some heat, which can degrade the quality of the image, for instance.


Various endoscopes and methods to manage, reduce and/or dissipate the heat output from the light source are disclosed in corresponding International Patent Application Serial No. PCT/CN2017/078143, filed on Mar. 24, 2017, the entire contents of which are incorporated by reference herein. Other endoscopes that include a passive thermal control system are disclosed in U.S. Patent Application Publication No. 2016/0007833, filed on Jun. 3, 2015, the entire contents of which being incorporated by reference herein.


With particular reference to FIGS. 8-15, an embodiment of an endoscope is shown and is generally referenced by character 1110. Endoscope 1110 is a laparoscope visualization system that includes a therapeutic unit for treating tissue.


Endoscope 1110 is shown in FIGS. 8-13 and includes a handle 1120 and an elongated portion 1114 extending distally from the handle 1120. A distal portion 1116 of the elongated portion 1114 includes an image sensor 1142, a lens 1144, a lens barrel 1146, a protective window 1147, a light source (e.g., LED light emitting elements) 1150, a therapeutic unit 1160 (e.g., LED light emitting elements or other sources of light), a sensor substrate 1180, and a light source substrate 1190. Distal portion 1116 of elongated portion 1114 terminates in a distal end 1118.


In the embodiment illustrated in FIG. 10, light source 1150 includes two LED light emitting elements 1150a and 1150b, and therapeutic unit 1160 includes two LED light emitting elements 1160a and 1160b. In the embodiment illustrated in FIG. 13, light source 1150 includes three LED light emitting elements 1150a, 1150b and 1150c, and therapeutic unit 1160 includes three LED light emitting elements 1160a, 1160b and 1160c. It is also contemplated and within the scope of the present disclosure for more or fewer LED light emitting elements of light source 1150 and therapeutic unit 1160 to be used in connection with endoscope 1110. Additionally, LED light emitting elements of light source 1150 and therapeutic unit 1160 may be any combination of white, red, green and blue light emitting elements, for example. For instance, it is envisioned that one LED light emitting element 1160a is red, one LED light emitting element 1160b is green, and the other LED light emitting element 1160c is blue for providing various types of therapy. Further details of LED light emitting elements of therapeutic unit 1160 are discussed below.


With particular reference to FIGS. 10, 11 and 13, LED light emitting elements 1150a-1150c of light source 1150 and LED light emitting elements 1160a-1160c of therapeutic unit 1160 are positioned radially outwardly of lens 1144 in an alternating pattern, and are engaged with (e.g., affixed to) light source substrate 1190, which is disposed distally of lens 1144. Sensor substrate 1180 is positioned proximally of lens 1144, and lens barrel 1146 extends distally from image sensor 1142 and from sensor substrate 1180. Lens 1144 is disposed within lens barrel 1146. Image sensor 1142 is engaged with or connected to (e.g., affixed to) sensor substrate 1180.


In embodiments, a processor 1155 is engaged with or connected to light source 1150 and therapeutic unit 1160, and is in electrical communication with a controller 1170 disposed within handle 1120.


In embodiments where endoscope 1110 includes controller 1170, controller 1170 is electrically connected to sensor substrate 1180 and light source substrate 1190 via cables, for example. The engagement between sensor substrate 1180 and image sensor 1142 results in an electrical connection between controller 1170 and image sensor 1142, and the engagement between light source substrate 1190 and light source 1150 and therapeutic unit 1160 results in an electrical connection between controller 1170, light source 1150 and therapeutic unit 1160.


With particular reference to FIG. 12, various components of the therapeutic unit 1160 are shown as they relate to one of the plurality of LED light emitting elements. Therapeutic unit 1160 includes an LED light emitting element (e.g., 1160a) engaged with light source substrate 1190, a lens barrel 1162 extending distally from light source substrate 1190, and a lens 1164 disposed within lens barrel 1162. As shown, lens 1164 is configured to focus the light emitted from LED light emitting element 1160a onto one point along the optical axis “0.” The optical axis is along or parallel to the longitudinal axis “x.” Accordingly, all of the light energy from each LED light emitting element 1160a, 1160b, 1160c, for example, can focus the light on a small area of tissue.


In particular, to help focus the light toward a particular point, a first or proximal surface 1164a of the lens 1164 is disposed at first angle α1 with respect to a first axis “A” which is perpendicular to the optical axis “0,” and a second or distal surface 1164b of the lens 1164 is disposed at a second angle α2 with respect to the first axis “A.” In disclosed embodiments, each of the first angle α1 and the second angle α2 is between about 5° and about 15° (approximately equal to about 10°). It is envisioned that the first angle α1 and the second angle α2 are functions of the distance of LED light emitting element (e.g., 1160) from the optical axis “0.” That is, the first angle α1 and the second angle α2 are larger as the distance from the optical axis “0” increases. It is also envisioned that the first angle α1 and the second angle α2 are the same value or different values.


One disclosed way of determining the shape of the lens 1164 is schematically illustrated in FIG. 12A. This method involves overlaying a first spherical lens 1164′ and a second spherical lens 1164″. The first spherical lens 1164′ has its center aligned with a center of LED light emitting element 1160a and collimates the light from LED light emitting element 1160a to propagate in a direction that is parallel with the optical axis “0.” It is envisioned that the LED light emitting element 1160a is located on the focus of the first spherical lens 1164′. The second spherical lens 1164″ has its center aligned with the optical axis “0” and focuses the collimated light which has passed the first spherical lens 1164′ to a point along the optical axis “0.” It is envisioned that this point along the optical axis “0” is the focus of the second spherical lens 1164″. Lens 1164 is thus formed by overlaying the first spherical lens 1164′ and a portion of the second spherical lens 1164″ (as shown in FIG. 12A).


Endoscope 1110 is configured to illuminate tissue, help a clinician view tissue, and/or to provide therapeutic treatment to tissue. When in use or open, therapeutic unit 1160 is configured to focus it light energy on a small area of tissue (relative to the amount of tissue that is illuminated by light source 1150). The tissue that is focused on absorbs the light energy from the therapeutic unit 1160 and thus increases in temperature. As the temperature of this tissue increases, some of the components of the tissue, such as protein, are broken down, which can have healing effects.


Since different parts of tissue have different absorption rates with respect to different wavelengths of lights, therapeutic unit 1160 can be controlled to produce light within various wavelengths for different healing effects. For example, when at least one LED light emitting element 1160a-1160c of therapeutic unit 1160 emits light with a wavelength raging from about 500 nm to about 600 nm, the blood within the tissue will coagulate from absorbing the light energy as the blood has a large absorption coefficient in this wavelength range (see FIGS. 14 and 15). Meanwhile, other components of tissue have a low absorption coefficient within this wavelength range which results in their temperature increasingly slowly and are thus not greatly influenced.


As another example, LEDs with a central wavelength of about 570 nm (e.g., corresponding to the color red) are able to induce fresh blood cells to produce strong fluorescence in living tissue. Further, red LEDs may be useful in providing therapy for relatively deep tissue (e.g., about 1 mm to about 5 mm from the tissue surface, approximately equal to about 3 mm) as the light within such a wavelength range has a larger penetration depth than ultraviolet light, for instance.


As yet another example, LEDs with a central wavelength of about 650 nm are able to kill gangrene cells.


Light energy produced by therapeutic unit 1160 can also be absorbed by cells and enhance the immunity features of white blood cells, for example.


The present disclosure also relates to method of treating tissue using endoscope 1110. The method includes using the light source 1150 of endoscope 1110 to illuminate tissue, using the image sensor 1142 of endoscope 1110 to visualize tissue, and using the therapeutic unit 1160 of endoscope 1110 to treat tissue.


It will be understood that various modifications may be made to the embodiments described herein. Therefore, the above description should not be construed as limiting, but merely as exemplifications of various embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended thereto.

Claims
  • 1. An endoscope comprising: a handle;an elongated body extending distally from the handle and defining a longitudinal axis, the elongated body including a distal portion;a source of light disposed within the distal portion of the elongated body and configured to illuminate tissue; anda therapeutic unit disposed within the distal portion of the elongated body and configured to treat tissue, the therapeutic unit including a light emitting element and a lens, the lens of the therapeutic unit is offset from the longitudinal axis and disposed distally of the light emitting element of the therapeutic unit, the lens of the therapeutic unit is configured to focus light emitted from the light emitting element of the therapeutic element towards the longitudinal axis, the lens of the therapeutic unit is formed by overlaying a portion of a first spherical lens and a portion of a second spherical lens, wherein: a center of the first spherical lens is offset from the longitudinal axis; anda center of the second spherical lens is axially aligned with the longitudinal axis.
  • 2. The endoscope according to claim 1, wherein the therapeutic unit includes a plurality of LED elements.
  • 3. The endoscope according to claim 1, further comprising a controller disposed in electrical communication with the source of light and with the therapeutic unit.
  • 4. The endoscope according to claim 1, further comprising an image sensor disposed within the distal portion of the elongated body and configured to capture a plurality of images.
  • 5. The endoscope according to claim 1, wherein the therapeutic unit is configured to focus the light energy on an area of tissue that is smaller than an area of tissue illuminated by the source of light.
  • 6. The endoscope according to claim 1, wherein the therapeutic unit is configured to emit light having a wavelength ranging from about 500 nm to about 650 nm.
  • 7. The endoscope according to claim 1, wherein the therapeutic unit includes one red light, one blue light and one green light.
  • 8. The endoscope according to claim 1, wherein the source of light includes at least one light emitting diode.
  • 9. The endoscope according to claim 1, wherein the lens of the therapeutic unit is configured to focus the light emitted from the light emitting element of the therapeutic element onto one point.
  • 10. The endoscope according to claim 1, wherein the center of the first spherical lens is axially aligned with a center of the light emitting element.
PCT Information
Filing Document Filing Date Country Kind
PCT/CN2017/078142 3/24/2017 WO
Publishing Document Publishing Date Country Kind
WO2018/170903 9/27/2018 WO A
US Referenced Citations (149)
Number Name Date Kind
4584988 Nishioka Apr 1986 A
5377669 Schulz Jan 1995 A
5436655 Hiyama Jul 1995 A
5718663 Wulfsberg Feb 1998 A
5813987 Modell Sep 1998 A
6204523 Carey et al. Mar 2001 B1
6260994 Matsumoto et al. Jul 2001 B1
6331156 Haefele et al. Dec 2001 B1
6449006 Shipp Sep 2002 B1
6488619 Miyanaga Dec 2002 B1
6503196 Kehr et al. Jan 2003 B1
6533722 Nakashima Mar 2003 B2
6569088 Koshikawa May 2003 B2
6627333 Hatwar Sep 2003 B2
6656112 Miyanaga Dec 2003 B2
6696703 Mueller-Mach et al. Feb 2004 B2
6796939 Hirata et al. Sep 2004 B1
6821246 Kasel et al. Nov 2004 B2
6918693 Ota et al. Jul 2005 B2
6921920 Kazakevich Jul 2005 B2
7119376 Liu et al. Oct 2006 B1
7183577 Mueller-Mach et al. Feb 2007 B2
7275931 Katsuda et al. Oct 2007 B2
7413543 Banik et al. Aug 2008 B2
7442167 Dunki-Jacobs et al. Oct 2008 B2
7488088 Brukilacchio Feb 2009 B2
7585273 Adler et al. Sep 2009 B2
7635330 Kang et al. Dec 2009 B2
7668450 Todd et al. Feb 2010 B2
7691056 Hirata Apr 2010 B2
7738940 Shoji et al. Jun 2010 B2
7749160 Hirata Jul 2010 B2
7931587 Yoshino Apr 2011 B2
7968901 Yamashita et al. Jun 2011 B2
7976459 Laser Jul 2011 B2
8029439 Todd et al. Oct 2011 B2
8043211 Hirata Oct 2011 B2
8123680 Kato et al. Feb 2012 B2
8211008 Henzler Jul 2012 B2
8246230 Todd et al. Aug 2012 B2
8400500 Hirata Mar 2013 B2
8414480 Kendale et al. Apr 2013 B2
8449457 Aizenfeld et al. May 2013 B2
8480566 Farr Jul 2013 B2
8485966 Robertson Jul 2013 B2
8556806 Farr Oct 2013 B2
8591408 St. George et al. Nov 2013 B2
8622896 Termanini Jan 2014 B1
8670028 Takasaki Mar 2014 B2
8790253 Sunagawa et al. Jul 2014 B2
8801255 Kudo Aug 2014 B2
8878920 Ovod Nov 2014 B2
9259140 Hirosawa Feb 2016 B2
9270919 Amling et al. Feb 2016 B2
9271630 Amling et al. Mar 2016 B2
9271637 Farr Mar 2016 B2
9277851 Stuehle et al. Mar 2016 B2
9307893 Kennedy, II et al. Apr 2016 B2
9319636 King Apr 2016 B2
9357902 Amling et al. Jun 2016 B2
9398839 Rehe Jul 2016 B2
9408525 Dahmen Aug 2016 B2
9498110 Asatori Nov 2016 B2
9520428 Fujimori Dec 2016 B2
9525852 Wodnicki et al. Dec 2016 B2
9782059 Saito et al. Oct 2017 B2
10111577 Weber et al. Oct 2018 B2
10213097 Kohno et al. Feb 2019 B2
10275905 Yamaki Apr 2019 B2
10285577 Czupalla et al. May 2019 B2
10708553 Sonoda Jul 2020 B2
10952600 Huang Mar 2021 B2
20020184122 Yamaguchi et al. Dec 2002 A1
20050049462 Kanazawa Mar 2005 A1
20050075538 Banik et al. Apr 2005 A1
20050124858 Matsuzawa Jun 2005 A1
20050203338 Couvillon, Jr. Sep 2005 A1
20060215406 Thrailkill Sep 2006 A1
20070173695 Hirata Jul 2007 A1
20070197873 Birnkrant Aug 2007 A1
20070225556 Ortiz et al. Sep 2007 A1
20070249904 Amano et al. Oct 2007 A1
20080045800 Farr Feb 2008 A2
20080064925 Gill Mar 2008 A1
20080077200 Bendett Mar 2008 A1
20080119740 Iddan May 2008 A1
20080158349 Miller Jul 2008 A1
20080200758 Orbay et al. Aug 2008 A1
20090058997 Kato Mar 2009 A1
20090154192 Krattiger Jun 2009 A1
20090247828 Watanabe et al. Oct 2009 A1
20100188493 Kanzaki et al. Jul 2010 A1
20100240953 Murakami Sep 2010 A1
20100286475 Robertson Nov 2010 A1
20100324632 Lim Dec 2010 A1
20110009694 Schultz et al. Jan 2011 A1
20110077465 Mizuyoshi et al. Mar 2011 A1
20110092772 Weber Apr 2011 A1
20110118547 Erikawa May 2011 A1
20110184244 Kagaya et al. Jul 2011 A1
20110263943 Yamaguchi Oct 2011 A1
20120041267 Benning Feb 2012 A1
20120071710 Gazdzinski Mar 2012 A1
20120209072 Oue et al. Aug 2012 A1
20120320581 Rogers et al. Dec 2012 A1
20130131451 Dillinger et al. May 2013 A1
20130265798 Kudo Oct 2013 A1
20130285094 Hsu et al. Oct 2013 A1
20130300847 Hashimoto Nov 2013 A1
20130334577 Ahn Dec 2013 A1
20140121468 Eichenholz May 2014 A1
20140128745 Willis May 2014 A1
20140316198 Krivopisk et al. Oct 2014 A1
20140330081 Imai Nov 2014 A1
20150094530 Moriya Apr 2015 A1
20150202456 Andersen Jul 2015 A1
20150222801 Kresser Aug 2015 A1
20150272422 Aoyama Oct 2015 A1
20150272442 Motafakker-Fard et al. Oct 2015 A1
20150297069 Coppersmith et al. Oct 2015 A1
20150366443 Liolios Dec 2015 A1
20160007833 Huang Jan 2016 A1
20160029879 Ishikawa Feb 2016 A1
20160058277 Selcho et al. Mar 2016 A1
20160073861 Kaneko Mar 2016 A1
20160077008 Takasu Mar 2016 A1
20160081533 Couvillon, Jr. Mar 2016 A1
20160105606 Hikita et al. Apr 2016 A1
20160106303 Birnkrant et al. Apr 2016 A1
20160106306 Furuta Apr 2016 A1
20160124211 Wieters et al. May 2016 A1
20160166132 Sasamoto et al. Jun 2016 A1
20160174823 Asatori et al. Jun 2016 A1
20160210411 Mentis Jul 2016 A1
20160213230 Adair et al. Jul 2016 A1
20160217255 Ukai et al. Jul 2016 A1
20160345814 Sidar Dec 2016 A1
20160353983 Onoe Dec 2016 A1
20170007095 Kutsuma et al. Jan 2017 A1
20170035511 Itoh et al. Feb 2017 A1
20170049312 Seth Feb 2017 A1
20170150873 Tatebayashi Jun 2017 A1
20170215714 Shinji Aug 2017 A1
20180098686 Tamiya Apr 2018 A1
20190150725 Ramanujam May 2019 A1
20190216325 Ouyang Jul 2019 A1
20190306467 Sonoda Oct 2019 A1
20190388175 Tatsuta Dec 2019 A1
20210100438 Ding Apr 2021 A1
Foreign Referenced Citations (19)
Number Date Country
1794944 Jun 2006 CN
101874914 Nov 2010 CN
102697449 Oct 2012 CN
105249919 Jan 2016 CN
106178279 Dec 2016 CN
106308727 Jan 2017 CN
1911389 Apr 2008 EP
2353493 Aug 2011 EP
2407087 Jan 2012 EP
2008117184 May 2008 JP
2010123858 Oct 2010 WO
2014004992 Jan 2014 WO
2014195843 Dec 2014 WO
2016017325 Feb 2016 WO
2016088512 Jun 2016 WO
2016117373 Jul 2016 WO
2018170903 Sep 2018 WO
2018170904 Sep 2018 WO
2019157763 Aug 2019 WO
Non-Patent Literature Citations (13)
Entry
Machine English Translation of CN106178279A, Cong Wei; Liang Xudong; Liu Jinlin, Interposition-type ultraviolet light therapeutic instrument and control method thereof.
Extended European Search Report dated Dec. 7, 2020 corresponding to counterpart Patent Application EP 17901503.7.
International Search Report dated Dec. 27, 2017 and Written Opinion completed Dec. 21, 2017 corresponding to counterpart Int'l Patent Application PCT/CN2017/078142.
Partial European Search Report corresponding to EP 15 17 6036.0 dated Nov. 25, 2015.
Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 15 17 6036.0, dated May 6, 2016.
European Office Action corresponding to counterpart Int'l Appln. No. EP 15 17 6036.0 dated Apr. 26, 2017.
Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201510405306 dated Dec. 5, 2017.
Chinese Second Office Action corresponding to counterpart Patent Application CN 201510405306 dated Jul. 31, 2018.
Australian Examination Report No. 1 corresponding to counterpart Patent Application AU 2015203154 dated Mar. 13, 2019.
Written Opinion completed Oct. 24, 2018 corresponding to Int'l Patent Application PCT/CN2018/076912.
Chinese Office Action dated Dec. 2, 2020 corresponding to counterpart Patent Application CN 2020112702421630.
Chinese Second Office Action dated Aug. 18, 2021 corresponding to counterpart Patent Application CN 201780088884.2.
Chinese Third Office Action dated Feb. 18, 2022 corresponding to counterpart Patent Application CN 201780088884.2.
Related Publications (1)
Number Date Country
20200016425 A1 Jan 2020 US